Literature DB >> 6975851

Three forms of dominant amyloid neuropathy.

G H Sack, K W Dumars, K S Gummerson, A Law, V A McKusick.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6975851

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN： 0021-7263


× No keyword cloud information.
  8 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

2.  Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.

Authors:  M Haltia; J Ghiso; F Prelli; G Gallo; S Kiuru; H Somer; J Palo; B Frangione
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

3.  Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type.

Authors:  J Ghiso; M Haltia; F Prelli; J Novello; B Frangione
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

4.  Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family.

Authors:  H S Stewart; R Parveen; A E Ridgway; R Bonshek; G C Black
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

5.  Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin.

Authors:  C P Maury
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Finnish type of familial amyloidosis: cosegregation of Asp187----Asn mutation of gelsolin with the disease in three large families.

Authors:  T Hiltunen; S Kiuru; V Hongell; T Heliö; J Palo; L Peltonen
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

7.  Immunohistochemical analysis of lattice corneal dystrophies types I and II.

Authors:  T Kivelä; A Tarkkanen; I McLean; J Ghiso; B Frangione; M Haltia
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

8.  Mutation in gelsolin gene in Finnish hereditary amyloidosis.

Authors:  E Levy; M Haltia; I Fernandez-Madrid; O Koivunen; J Ghiso; F Prelli; B Frangione
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.